DIANA PENA: Open Payments
NPI 1053035477 · WINNETKA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 15 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $139 · 2025 $724
Food & beverage: $705Travel & lodging: $19
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $342 |
| Otsuka America Pharmaceutical, Inc. | 4 | $191 |
| ABBVIE INC. | 4 | $86 |
| Janssen Pharmaceuticals, Inc | 3 | $81 |
| Alkermes, Inc. | 1 | $24 |
Products named: INGREZZA, ABILIFY MAINTENA, VRAYLAR, SPRAVATO, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across CA — which companies pay providers there.
